Showing results (251-260 of 269) with videos related to

Sort By:
Pageof 27
Diabetes Technology & Therapeutics|October 2, 2023
Safety and Glycemic Outcomes During the MiniMed<sup>TM</sup> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 DiabetesCatherine Pihoker, Dorothy I Shulman, Gregory P Forlenza, et al.
Diabetes Technology & Therapeutics|March 10, 2021
Predictors of Time-in-Range (70-180 mg/dL) Achieved Using a Closed-Loop Control SystemMelissa J Schoelwer, Lauren G Kanapka, R Paul Wadwa, et al.
Hormone Research in Paediatrics|December 10, 2024
The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)Othmar Moser, Dessi Zaharieva, Peter Adolfsson, et al.
Diabetologia|December 9, 2024
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD)Othmar Moser, Dessi P Zaharieva, Peter Adolfsson, et al.
Diabetes Care|June 8, 2021
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 DiabetesSue A Brown, Gregory P Forlenza, Bruce W Bode, et al.
Diabetes, Obesity & Metabolism|July 15, 2022
Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parentsKorey K Hood, Natasha Garcia-Willingham, Sarah Hanes, et al.
Nature|August 10, 2000
Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and leanJ C Clapham, J R Arch, H Chapman, et al.
Diabetes Technology & Therapeutics|December 16, 2020
First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 DiabetesGregory P Forlenza, Bruce A Buckingham, Sue A Brown, et al.
Diabetes Technology & Therapeutics|July 9, 2014
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sitesHoward Zisser, Eric Renard, Boris Kovatchev, et al.
Diabetes Care|May 22, 2016
Multinational Home Use of Closed-Loop Control Is Safe and EffectiveStacey M Anderson, Dan Raghinaru, Jordan E Pinsker, et al.
Pageof 27